- Home
- MPX vs PRQR Comparison
MPX vs PRQR Comparison
Compare MPX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- PRQR
- Stock Information
- Founded
- MPX 1965
- PRQR 2012
- Country
- MPX United States
- PRQR Netherlands
- Employees
- MPX N/A
- PRQR N/A
- Industry
- MPX Marine Transportation
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- PRQR Health Care
- Exchange
- MPX Nasdaq
- PRQR Nasdaq
- Market Cap
- MPX 297.8M
- PRQR 179.1M
- IPO Year
- MPX N/A
- PRQR 2014
- Fundamental
- Price
- MPX $9.10
- PRQR $2.18
- Analyst Decision
- MPX Hold
- PRQR Strong Buy
- Analyst Count
- MPX 1
- PRQR 8
- Target Price
- MPX $8.00
- PRQR $8.88
- AVG Volume (30 Days)
- MPX 26.2K
- PRQR 371.0K
- Earning Date
- MPX 07-24-2025
- PRQR 08-07-2025
- Dividend Yield
- MPX 6.15%
- PRQR N/A
- EPS Growth
- MPX N/A
- PRQR N/A
- EPS
- MPX 0.43
- PRQR N/A
- Revenue
- MPX $226,217,000.00
- PRQR $21,212,711.00
- Revenue This Year
- MPX $3.97
- PRQR N/A
- Revenue Next Year
- MPX $13.02
- PRQR N/A
- P/E Ratio
- MPX $21.10
- PRQR N/A
- Revenue Growth
- MPX N/A
- PRQR 85.91
- 52 Week Low
- MPX $7.49
- PRQR $1.07
- 52 Week High
- MPX $10.89
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- MPX 63.17
- PRQR 65.20
- Support Level
- MPX $8.46
- PRQR $1.89
- Resistance Level
- MPX $8.97
- PRQR $2.54
- Average True Range (ATR)
- MPX 0.35
- PRQR 0.13
- MACD
- MPX 0.09
- PRQR 0.01
- Stochastic Oscillator
- MPX 100.00
- PRQR 39.85
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the powerboat manufacturing business segment in Nashville, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats, and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.